Journals / Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi / 2015 / Cilt: 29 - Sayı: 3

Two-Dimensional Conventional Radiotherapy Versus Intensity Modulated Radiotherapy for Nasopharyngeal Cancer Treatment: A Retrospective Study from Northeast Turkey

Nazofarenks Kanseri Tedavisinde İki Boyutlu Konformal Radyoterapi ile Yoğunluk Ayarlı Radyoterapinin Karşılaştırılması: Türkiye'nin Kuzeyinde Retrospektif Bir Çalışma

Pages
123–130
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: IMRT was better than 2DCRT for treatment of NPC considering treatment compliance, toxicity, and tumor response; however, prospective studies with more patients are needed for confirmation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aims to compare intensity-modulated radiotherapy (IMRT) and twodimensional conventional radiotherapy (2DCRT) considering treatment response, treatment compliance, and toxicity in nasopharyngeal cancer (NPC) patients.
📊
Key Findings & Data:Materials and Methods: A total of 78 NPC patients admitted between January 1999- December 2013 were retrospectively evaluated for local control (LC), treatment compliance, and toxicity.
💡
Conclusion & Impact:Conclusion: IMRT was better than 2DCRT for treatment of NPC considering treatment compliance, toxicity, and tumor response; however, prospective studies with more patients are needed for confirmation.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: This study aims to compare intensity-modulated radiotherapy (IMRT) and twodimensional conventional radiotherapy (2DCRT) considering treatment response, treatment compliance, and toxicity in nasopharyngeal cancer (NPC) patients. Materials and Methods: A total of 78 NPC patients admitted between January 1999- December 2013 were retrospectively evaluated for local control (LC), treatment compliance, and toxicity. Of these, 55 (70.5%) were treated with 2DCRT, and 23 (29.5%) were treated with IMRT. Results: The median follow-up time was 34.1 months (range, 3.2-202.84). Xerostomia was the most common acute toxicity in both the 2DCRT (41, 77.4%) and IMRT (18, 78.3%) groups. The most common late toxicity occurred in 28 (51.9%) patients in the former was xerostomia, while that in the latter was soft tissue fibrosis in 13 (56.6%) patients. No differences between these treatments were observed considering acute or late toxicity. In the former, 23 patients (41.8%) interrupted the treatment, while in the latter only 4 patients (17.4%) interrupted it. This difference was statistically significant. Considering treatment response, no significant difference was noted. Conclusion: IMRT was better than 2DCRT for treatment of NPC considering treatment compliance, toxicity, and tumor response; however, prospective studies with more patients are needed for confirmation.

Özet

Amaç: İki boyutlu konformal radyoterapi (2DCRT) ile yoğunluk ayarlı radyoterapinin (IMRT) tedavi cevabı, tedaviye uyum ve yan etkiler açısından retrospektif olarak kaşlılaştırılması amaçlanmıştır. Gereç ve Yöntem: Ocak 1999-Aralık 2013 tarihleri arasında nazofarenks kanseri (NFC) tanısıyla başvuran 78 hasta, tedavi cevabı, tedaviye uyum ve yan etki açısından değerlendirilmeye alındı. 55'i (%70.5) 2DCRT ile 23'ü (%29.5) IMRT ile tedavi edilmiştir. Olguların E/K oranı 2.7 olup medyan ortalama yaş 46 'dır. Olguların 5'i (%6.4) evre 1, 12'si (%15.4) evre 2, 39'u (%50) evre 3, 22 (%28.2) evre 4 tür. Bulgular: Medyan izlem süresi 34.1 ay (3.2-202.84)'dır. Akut yan etki 2DCRT ve IMRT uygulananlarda en sık kserestomi olup sırası ile 41 (%77.4) ve 18 (%78.3) dir. Geç toksisite olarak 2DCRT uygulananlarda en sık 28 (%51.9) hastada kserestomi, IMRT uygulananlarda ise en sık 13 (%56.5) hastada yumuşak doku fibrosizi görülmüştür. RT tedavisi boyunca ve izlem süresince görülen akut ve kronik yan etkiler açısından 2DCRT ve IMRT arasında fark görülmemiş olup, sırasıyla P değerleri (P=0.398), (P=0.692) ve (P=0.332) şeklindedir 2DCRT tedavisi gören hastaların (23) %41.8'i tedaviye ara verirken, IMRT tedavisi alanların sadece (4) %17.4'ü tedaviye ara vermiştir ve bu istatistiksel olarak anlamlı bulunmuştur (P=0.039). Tedavi cevabı açısından iki grup arasında fark görülmemiştir (P=0.736). Sonuç: Nazofarenks kanserinde 2DCRT ile IMRT kaşlılaştırıldığında tedaviye uyum, yan etkiler ve tümör cevabı için IMRT daha üstün görülmektedir.

🔖

Cite This Article

YÖNEY, A., SERDAR, L., CANYILMAZ, E., USLU, G. H., GÖÇMEZ, H., ZENGİN, A. (2022). Two-Dimensional Conventional Radiotherapy Versus Intensity Modulated Radiotherapy for Nasopharyngeal Cancer Treatment: A Retrospective Study from Northeast Turkey. Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, Cilt: 29 - Sayı: 3, 123–130. https://ajindex.com/articles/514615

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Helperin EC, Perez CA, Wallner K, Brady LW. Nasopharynx in Principles Practice of Radiation Oncology. Fifty Edition, Philadelphia: Lpincott Williams, 2008
  2. Özyar E, Yıldız F, Akyol F, Atahan L. Adjuvant high-doserare brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2002; 52: 101-108
  3. International Nasopharynx Cancer Study Group, VUMCA I trial. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV(>or=N2 M0) undifferantiated nasopharyngeal carcinoma: A positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 1996; 35: 463-469
  4. Chan AT, Leung SF, Ngan RK, et al. Overall survival after concurrent cisplatin-radiotherapy alone in locoregionally advenced nasopharyngeal carcinoma. J Natl Cancer Inst 2005; 97: 536-539
  5. Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006; 66: 981-991
  6. Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007; 25: 4873-4879
  7. Teo P, Yu P, Lee WY, et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 1996; 36: 291- 304
  8. Lee AW, Law SC, Foo W, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: Survival after local recurrence. Int J Radiat Oncol Biol Phys 1993; 26: 773-782
  9. Perez CA, Devineni VR, Marcial-Vega V, et al. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992; 23: 271-280
  10. Sanguineti G, Geara F, Garden A, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control. Int J Radiat Oncol Biol Phys 1997; 37: 985-996
  11. Vikram B, Mishra UB, Strong EW, et al. Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys 1985; 11: 1455-1459
  12. Marks JE, Bedwinek JM, Lee F, et al. Dose-response analysis for nasopharyngeal carcinoma: An historical perspective. Cancer 19